• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2010 Fiscal Year Final Research Report

Novel therapeutic strategy of the fatal arrhythmia targeting specific domain in the ryanodine receptor molecle

Research Project

  • PDF
Project/Area Number 20590868
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionYamaguchi University

Principal Investigator

YAMAMOTO Takeshi  Yamaguchi University, 大学院・医学系研究科, 助教 (50363122)

Co-Investigator(Kenkyū-buntansha) KOBAYASHI Shigeki  山口大学, 医学部附属病院, 助教 (90397993)
Project Period (FY) 2008 – 2010
Keywords分子心臓病態学 / 致死的不整脈
Research Abstract

We identified the important RyR2 domain for the stabilization of the RyR2 channel as domain 2114-2149 and its counterpart. The counterpart of domain 2114-2149 is in the central portion of the RyR2. The compound which affect these two domains might be novel medicines for heart failure of fatal arrhythmias.

  • Research Products

    (17 results)

All 2011 2010 2009 2008 Other

All Journal Article (12 results) (of which Peer Reviewed: 12 results) Presentation (3 results) Book (1 results) Remarks (1 results)

  • [Journal Article] Isoform-specific roles of protein phosphatase 1 catalytic subunits in sarcoplasmic reticulum-mediated Ca2+ cycling.2011

    • Author(s)
      Aoyama H, Ikeda Y, Miyazaki Y, Yoshimura K, Nishino S, Yamamoto T, Yano M, Inui M, Aoki H, Matsuzaki M.
    • Journal Title

      Cardiovasc Res. 89(1)

      Pages: 79-88

    • Peer Reviewed
  • [Journal Article] Urinary 8-Hydroxy-2' -Deoxyguanosine Reflects Symptomatic Status and Severity of Systolic Dysfunction in Patients with Chronic Heart Failure.2011

    • Author(s)
      Kobayashi S, Susa T, Tanaka T, Wada Y, Okuda S, Doi M, Nao T, Yoshiga Y, Yamada J, Okamura T, Ueyama T, Kawamura S, Yano M, Matsuzaki M.
    • Journal Title

      Eur J Heart Fail. 13(1)

      Pages: 29-36

    • Peer Reviewed
  • [Journal Article] Dantrolene, a therapeutic agent for malignant hyperthermia inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2 R2474S/+knock-in mouse model.2010

    • Author(s)
      Kobayashi S, Yano M, Uchinoumi H, Suetomi T, Susa T, Ono M, Xu X, Tateishi H, Oda T, Okuda S, Doi M, Yamamoto T, Matsuzaki M.
    • Journal Title

      Circ J. 74(12)

      Pages: 2579-2584

    • Peer Reviewed
  • [Journal Article] Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca2+ release in heart failure.2010

    • Author(s)
      Ono M, Yano M, Hino A, Suetomi T, Xu X, Susa T, Uchinoumi H, Tateishi H, Oda T, Okuda S, Doi M, Kobayashi S, Yamamoto T, Koseki N, Kyushiki H, Ikemoto N, Matsuzaki M.
    • Journal Title

      Cardiovasc Res. 87(4)

      Pages: 609-617

    • Peer Reviewed
  • [Journal Article] Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction.2010

    • Author(s)
      Xu X, Yano M, Uchinoumi H, Hino A, Suetomi T, Ono M, Tateishi H, Oda T, Okuda S, Doi M, Kobayashi S, Yamamoto T, lkeda Y, lkemoto N, Matsuzaki M.
    • Journal Title

      Biochem Biophys Res Commun. 394(3)

      Pages: 660-666

    • Peer Reviewed
  • [Journal Article] Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.2010

    • Author(s)
      Uchinoumi H, Yano M, Suetomi T, Ono M, Xu X, Tateishi H, Oda T, Okuda S, Doi M, Kobayashi S, Yamamoto T, lkeda Y, Ohkusa T, lkemoto N, Matsuzaki M.
    • Journal Title

      Circ Res. 106(8)

      Pages: 1413-1424

    • Peer Reviewed
  • [Journal Article] Norepinephrine spillover during exercise as a novel parameter to evaluate the severity of heart failure.2010

    • Author(s)
      Ando M, Yamamoto T, Hino A, Sato T, Nakamura Y, Matsuzaki M.
    • Journal Title

      J Nucl Cardiol. 17(5)

      Pages: 868-873

    • Peer Reviewed
  • [Journal Article] Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor.2009

    • Author(s)
      Kobayashi S, Yano M, Suetomi T, Ono M, Tateishi H, Mochizuki M, Xu X, Uchinoumi H, Okuda S, Yamamoto T, Koseki N, Kyushiki H, lkemoto N, Matsuzaki M.
    • Journal Title

      J Am Coll Cardiol. 53(21)

      Pages: 1993-2005

    • Peer Reviewed
  • [Journal Article] Role of ryanodine receptor as a Ca2+ regulatory center in normal and failing hearts.2009

    • Author(s)
      Yano M, Yamamoto T, Kobayashi S, Matsuzaki M.
    • Journal Title

      J Cardiol. 53(1)

      Pages: 1-7

    • Peer Reviewed
  • [Journal Article] Defective domain-domain interactions within the ryanodine receptor as a critical cause of diastolic Ca2+ leak in failing hearts.2009

    • Author(s)
      Tateishi H, Yano M, Mochizuki M, Suetomi T, Ono M, Xu X, Uchinoumi H, Okuda S, Oda T, Kobayashi S, Yamamoto T, Ikeda Y, Ohkusa T, Ikemoto N, Matsuzaki M.
    • Journal Title

      Cardiovasc Res. 81(3)

      Pages: 536-545

    • Peer Reviewed
  • [Journal Article] Defective Ca2+ cycling as a key pathogenic mechanism of heart failure.2008

    • Author(s)
      Yano M, Yamamoto T, Kobayashi S, Ikeda Y, Matsuzaki M.
    • Journal Title

      Circ J. 72

      Pages: SupplA : A22-30

    • Peer Reviewed
  • [Journal Article] Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts.2008

    • Author(s)
      Yamamoto T, Yano M, Xu X, Uchinoumi H, Tateishi H, Mochizuki M, Oda T, Kobayashi S, Ikemoto N, Matsuzaki M.
    • Journal Title

      Circulation. 117(6)

      Pages: 762-772

    • Peer Reviewed
  • [Presentation] Interruption of Novel Inter-domain Interaction Within RyR2 as a Common Therapeutic Target by Channel Stabilization in Heart Failure and Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)2010

    • Author(s)
      Takeshi Yamamoto, Masafumi Yano, Masahiro Fukuda, Akihiro Hino, Takeshi Suetomi, Masahiro Doi, Shinich Okuda, Shigeki Kobayashi, Masunori Matsuzaki
    • Organizer
      American Heart Association Scientific Sessions
    • Place of Presentation
      Chicago IL, USA
    • Year and Date
      2010-11-15
  • [Presentation] Domain2114-2149 Within RyR2 Plays a Key Role for Correcting Channel Disorder in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)2008

    • Author(s)
      Yamamoto, T, Yano, M, Suedomi, T, Ohno, M, Xu, XJ, Tateishi, H, Okuda, S, Kobayashi, S, Ikeda, Y, Matsuzaki, M
    • Organizer
      Scientific Sessions 2008 of American Heart Association
    • Place of Presentation
      NewOrleans, USA
    • Year and Date
      20081108-20081112
  • [Presentation] Identification of Target Domains of the Cardiac Ryanodine Receptor to Correct Channel Disorder in Failing Hearts2008

    • Author(s)
      Yamamoto, T, Yano, M, Suedomi, T, Ohno, M, Xu, XJ, Tateishi, H, Okuda, S, Kobayashi, S, Ikeda, Y, Matsuzaki, M
    • Organizer
      Basic Cardiovascular Sciences Annual Conference 2009-Molecular Mechanisms of Cardiovascular Disease.
    • Place of Presentation
      Keystone, USA
    • Year and Date
      20080720-20080723
  • [Book] Heart Failure Pathophyiology in upportive Care in Heart Failure.2008

    • Author(s)
      Ikeda Y, Yamamoto T, Yano M, Matsuzaki M.
    • Total Pages
      27-47
    • Publisher
      Oxford University Press. Ch.
  • [Remarks] ホームページ等 なし

URL: 

Published: 2012-01-26   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi